Company profile
Medilink Therapeutics company profile
MediLink Therapeutics has established its R&D center in Suzhou, China. The company focuses on developing next generation drug conjugates, and aims to serve the vast unmet medical needs in China, and create global value through conducting multicenter clinical trials and cross-border collaborations.
Business identity
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 51-100 employees
- Revenue range
- $1M-$10M
- Founded
- 2020-01-01, Year
Headquarters
- Headquarters
- Fucheng, Shanxi, China
- Country code
- CN
- Continent
- Asia